Jadhav, K.; Abhang, A.; Kole, E.B.; Gadade, D.; Dusane, A.; Iyer, A.; Sharma, A.; Rout, S.K.; Gholap, A.D.; Naik, J.;
et al. Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress. Bioengineering 2025, 12, 481.
https://doi.org/10.3390/bioengineering12050481
AMA Style
Jadhav K, Abhang A, Kole EB, Gadade D, Dusane A, Iyer A, Sharma A, Rout SK, Gholap AD, Naik J,
et al. Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress. Bioengineering. 2025; 12(5):481.
https://doi.org/10.3390/bioengineering12050481
Chicago/Turabian Style
Jadhav, Krishna, Ashwin Abhang, Eknath B. Kole, Dipak Gadade, Apurva Dusane, Aditya Iyer, Ankur Sharma, Saroj Kumar Rout, Amol D. Gholap, Jitendra Naik,
and et al. 2025. "Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress" Bioengineering 12, no. 5: 481.
https://doi.org/10.3390/bioengineering12050481
APA Style
Jadhav, K., Abhang, A., Kole, E. B., Gadade, D., Dusane, A., Iyer, A., Sharma, A., Rout, S. K., Gholap, A. D., Naik, J., Verma, R. K., & Rojekar, S.
(2025). Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress. Bioengineering, 12(5), 481.
https://doi.org/10.3390/bioengineering12050481
